From Profits to Risk Factors: A Comprehensive Analysis of Becton, Dickinson and Company (BDX) SEC 10-Q Filing
In the first quarter of 2025, the company celebrated a surge in revenue, primarily from Medication Delivery Solutions and Advanced Patient Monitoring. However, challenges emerged from declines in Pharmaceutical Systems...









